Recombinant Human Interleukin-24 Suppresses Gastric Carcinoma Cell Growth In Vitro and In Vivo

REFERENCES

• Jemal, A.; Tiwari, R.C.; Murray, T.; Ghafoor, A.; Samuels, A.; Ward, E.; Feuer, E.J.; Thun, M.J. Cancer statistics, 2004. CA Cancer J Clin 2004, 54, 8–29.
   PubMed Web of Science ®Google Scholar
• Jiang, H.; Lin, J.J.; Su, Z.Z.; Goldstein, N.I.; Fisher, P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995, 11, 2477–2486.
   PubMed Web of Science ®Google Scholar
• Sauane, M.; Gopalkrishnan, R.V.; Sarkar, D.; Su, Z.Z.; Lebedeva, I.V.; Dent, P.; Pestka, S.; Fisher, P.B. Mda-7/il-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev 2003, 14, 35–51.
   PubMed Web of Science ®Google Scholar
• Chada, S.; Sutton, R.B.; Ekmekcioglu, S.; Ellerhorst, J.; Mumm, J.B.; Leitner, W.W.; Yang, H.Y.; Sahin, A.A.; Hunt, K.K.; Fuson, K.L.; Poindexter, N.; Roth, J.A.; Ramesh, R.; Grimm, E.A.; Mhashilkar, A.M. Mda-7/il-24 is a unique cytokine–tumor suppressor in the il-10 family. Int Immunopharmacol 2004, 4, 649–667.
   PubMed Web of Science ®Google Scholar
• Lebedeva, I.V.; Su, Z.Z.; Chang, Y.; Kitada, S.; Reed, J.C.; Fisher, P.B. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 2002, 21, 708–718.
   PubMed Web of Science ®Google Scholar
• Su, Z.Z.; Lebedeva, I.V.; Sarkar, D.; Gopalkrishnan, R.V.; Sauane, M.; Sigmon, C.; Yacoub, A.; Valerie, K.; Dent, P.; Fisher, P.B. Melanoma differentiation associated gene-7, mda-7/il-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 2003, 22, 1164–1180.
   PubMed Web of Science ®Google Scholar
• Saeki, T.; Mhashilkar, A.; Swanson, X.; Zou-Yang, X.H.; Sieger, K.; Kawabe, S.; Branch, C.D.; Zumstein, L.; Meyn, R.E.; Roth, J.A.; Chada, S.; Ramesh, R. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene 2002, 21, 4558–4566.
   PubMed Web of Science ®Google Scholar
• Saito, Y.; Miyahara, R.; Gopalan, B.; Litvak, A.; Inoue, S.; Shanker, M.; Branch, C.D.; Mhashilkar, A.M.; Roth, J.A.; Chada, S.; Ramesh, R. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated-7 (mda-7)/interleukin-24 (il-24) gene. Cancer Gene Ther 2005, 12, 238–247.
   PubMed Web of Science ®Google Scholar
• Su, Z.Z.; Madireddi, M.T.; Lin, J.J.; Young, C.S.; Kitada, S.; Reed, J.C.; Goldstein, N.I.; Fisher, P.B. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci USA 1998, 95, 14400–14405.
   PubMed Web of Science ®Google Scholar
• Wei, L.; Wang, Z.; Cui, T.; Yi, F.; Bu, Y.; Ding, S.; Ma, Y.; Song, F. Proteomic analysis of cervical cancer cells treated with adenovirus-mediated mda-7. Cancer Biol Ther 2008, 7, 510–516.
   PubMed Web of Science ®Google Scholar
• Zhao, L.; Gu, J.; Dong, A.; Zhang, Y.; Zhong, L.; He, L.; Wang, Y.; Zhang, J.; Zhang, Z.; Huiwang, J.; Qian, Q.; Qian, C.; Liu, X. Potent antitumor activity of oncolytic adenovirus expressing mda-7/il-24 for colorectal cancer. Hum Gene Ther 2005, 16, 845–858.
   PubMed Web of Science ®Google Scholar
• Caudell, E.G.; Mumm, J.B.; Poindexter, N.; Ekmekcioglu, S.; Mhashilkar, A.M.; Yang, X.H.; Retter, M.W.; Hill, P.; Chada, S.; Grimm, E.A. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated il-24. J Immunol 2002, 168, 6041–6046.
   PubMed Web of Science ®Google Scholar
• Ferrantini, M.; Belardelli, F. Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications. Semin Cancer Biol 2000, 10, 145–157.
   PubMed Web of Science ®Google Scholar
• Tasaki, K.; Yoshida, Y.; Maeda, T.; Miyauchi, M.; Kawamura, K.; Takenaga, K.; Yamamoto, H.; Kouzu, T.; Asano, T.; Ochiai, T.; Sakiyama, S.; Tagawa, M. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper t cells. Cancer Gene Ther 2000, 7, 247–254.
   PubMed Web of Science ®Google Scholar
• Halin, C.; Rondini, S.; Nilsson, F.; Berndt, A.; Kosmehl, H.; Zardi, L.; Neri, D. Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature. Nat Biotechnol 2002, 20, 264–269.
   PubMed Web of Science ®Google Scholar
• Sarkar, D.; Su, Z.Z.; Lebedeva, I.V.; Sauane, M.; Gopalkrishnan, R.V.; Dent, P.; Fisher, P.B. Mda-7 (il-24): signaling and functional roles. Biotechniques 2002. (Suppl.), 30–39.
   PubMed Web of Science ®Google Scholar
• Ye, Z.; Wang, X.; Hao, S.; Zhong, J.; Xiang, J.; Yang, J. Oncolytic adenovirus-mediated e1a gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal model. Cancer Biother Radiopharm 2006, 21, 225–234.
   PubMed Web of Science ®Google Scholar
• Wang, D.; Lippard, S.J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005, 4, 307–320.
   PubMed Web of Science ®Google Scholar
• Huang, T.; Zhang, Y.; Wang, J.; Huang, J.; Liu, D.; Mong, S. Pingyangmycin as a 99mtc carrier in tumor localization. Nucl Med Biol 1995, 22, 537–542.
   PubMed Web of Science ®Google Scholar
• Weidner, N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995, 36, 169–180.
   PubMed Web of Science ®Google Scholar
• Chen, Z.; Moyana, T.; Saxena, A.; Warrington, R.; Jia, Z.; Xiang, J. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int J Cancer 2001, 93, 539–548.
   PubMed Web of Science ®Google Scholar
• Cao, X.X.; Mohuiddin, I.; Chada, S.; Mhashilkar, A.M.; Ozvaran, M.K.; McConkey, D.J.; Miller, S.D.; Daniel, J.C.; Smythe, W.R. Adenoviral transfer of mda-7 leads to bax up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of bcl-xl. Mol Med 2002, 8, 869–876.
   PubMed Web of Science ®Google Scholar
• Pataer, A.; Vorburger, S.A.; Barber, G.N.; Chada, S.; Mhashilkar, A.M.; Zou-Yang, H.; Stewart, A.L.; Balachandran, S.; Roth, J.A.; Hunt, K.K.; Swisher, S.G. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded rna-dependent protein kinase (pkr). Cancer Res 2002, 62, 2239–2243.
   PubMed Web of Science ®Google Scholar
• Sarkar, D.; Su, Z.Z.; Lebedeva, I.V.; Sauane, M.; Gopalkrishnan, R.V.; Valerie, K.; Dent, P.; Fisher, P.B. Mda-7 (il-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the gadd family of genes by means of p38 mapk. Proc Natl Acad Sci USA 2002, 99, 10054–10059.
   PubMed Web of Science ®Google Scholar
• Gopalan, B.; Litvak, A.; Sharma, S.; Mhashilkar, A.M.; Chada, S.; Ramesh, R. Activation of the fas-fasl signaling pathway by mda-7/il-24 kills human ovarian cancer cells. Cancer Res 2005, 65, 3017–3024.
   PubMed Web of Science ®Google Scholar
• Sieger, K.A.; Mhashilkar, A.M.; Stewart, A.; Sutton, R.B.; Strube, R.W.; Chen, S.Y.; Pataer, A.; Swisher, S.G.; Grimm, E.A.; Ramesh, R.; Chada, S. The tumor suppressor activity of mda-7/il-24 is mediated by intracellular protein expression in nsclc cells. Mol Ther 2004, 9, 355–367.
   PubMed Web of Science ®Google Scholar
• Mhashilkar, A.M.; Stewart, A.L.; Sieger, K.; Yang, H.Y.; Khimani, A.H.; Ito, I.; Saito, Y.; Hunt, K.K.; Grimm, E.A.; Roth, J.A.; Meyn, R.E.; Ramesh, R.; Chada, S. Mda-7 negatively regulates the beta-catenin and pi3k signaling pathways in breast and lung tumor cells. Mol Ther 2003, 8, 207–219.
   PubMed Web of Science ®Google Scholar
• Wang, M.; Tan, Z.; Zhang, R.; Kotenko, S.V.; Liang, P. Interleukin 24 (mda-7/mob-5) signals through two heterodimeric receptors, il-22r1/il-20r2 and il-20r1/il-20r2. J Biol Chem 2002, 277, 7341–7347.
   PubMed Web of Science ®Google Scholar
• Wolk, K.; Kunz, S.; Witte, E.; Friedrich, M.; Asadullah, K.; Sabat, R. Il-22 increases the innate immunity of tissues. Immunity 2004, 21, 241–254.
   PubMed Web of Science ®Google Scholar
• Nagalakshmi, M.L.; Murphy, E.; McClanahan, T.; de Waal Malefyt, R. Expression patterns of il-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 2004, 4, 577–592.
   PubMed Web of Science ®Google Scholar
• Ishikawa, M.; Kitayama, J.; Kazama, S.; Nagawa, H. Expression of vascular endothelial growth factor c and d (vegf-c and -d) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol 2003, 33, 21–27.
   PubMed Web of Science ®Google Scholar
• Ramesh, R.; Mhashilkar, A.M.; Tanaka, F.; Saito, Y.; Branch, C.D.; Sieger, K.; Mumm, J.B.; Stewart, A.L.; Boquoi, A.; Dumoutier, L.; Grimm, E.A.; Renauld, J.C.; Kotenko, S.; Chada, S. Melanoma differentiation-associated gene 7/interleukin (il)-24 is a novel ligand that regulates angiogenesis via the il-22 receptor. Cancer Res 2003, 63, 5105–5113.
   PubMed Web of Science ®Google Scholar
• Tedjarati, S.; Baker, C.H.; Apte, S.; Huang, S.; Wolf, J.K.; Killion, J.J.; Fidler, I.J. Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel. Clin Cancer Res 2002, 8, 2413–2422.
   PubMed Web of Science ®Google Scholar
• Inoue, K.; Chikazawa, M.; Fukata, S.; Yoshikawa, C.; Shuin, T. Frequent administration of angiogenesis inhibitor tnp-470 (agm-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder. Clin Cancer Res 2002, 8, 2389–2398.
   PubMed Web of Science ®Google Scholar
• Hirata, A.; Ogawa, S.; Kometani, T.; Kuwano, T.; Naito, S.; Kuwano, M.; Ono, M. Zd1839 (iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res 2002, 62, 2554–2560.
   PubMed Web of Science ®Google Scholar
• Emdad, L.; Lebedeva, I.V.; Su, Z.Z.; Gupta, P.; Sarkar, D.; Settleman, J.; Fisher, P.B. Combinatorial treatment of non-small-cell lung cancers with gefitinib and ad.Mda-7 enhances apoptosis-induction and reverses resistance to a single therapy. J Cell Physiol 2007, 210, 549–559.
   PubMed Web of Science ®Google Scholar
• Dvorak, H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002, 20, 4368–4380.
   PubMed Web of Science ®Google Scholar